COMPANY
SpectraGenetics
NIH awards 15
- NIH award 5R44MH122115-05 FY2024: $893,166 awarded for that fiscal year; activity R44 (SBIR); PI ASBURY, G. REID; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. Highly Multiplexed Cell-Based GPCR Assay. source ↗
- NIH award 3R44MH122115-04S1 FY2023: $307,673 awarded for that fiscal year; activity R44 (SBIR); PI ASBURY, G. REID; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. Highly Multiplexed Cell-Based GPCR Assay. source ↗
- NIH award 5R44MH122115-04 FY2023: $661,142 awarded for that fiscal year; activity R44 (SBIR); PI ASBURY, G. REID; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. Highly Multiplexed Cell-Based GPCR Assay. source ↗
- NIH award 4R44MH122115-03 FY2022: $711,325 awarded for that fiscal year; activity R44 (SBIR); PI ASBURY, G. REID; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. Highly Multiplexed Cell-Based GPCR Assay. source ↗
- NIH award 1R41CA257114-01 FY2021: $222,717 awarded for that fiscal year; activity R41 (STTR); PI JARVIK, JONATHAN W; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. Highly multiplexed live-cell GPCR arrays for source ↗
- NIH award 5R44MH122115-02 FY2021: $425,279 awarded for that fiscal year; activity R44 (SBIR); PI ASBURY, G. REID; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. Highly Multiplexed Cell-Based GPCR Assay. source ↗
- NIH award 1R44MH122115-01 FY2020: $431,799 awarded for that fiscal year; activity R44 (SBIR); PI ASBURY, G. REID; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. Highly Multiplexed Cell-Based GPCR Assay. source ↗
- NIH award 5R43MH111295-02 FY2017: $230,519 awarded for that fiscal year; activity R43 (SBIR); PI ASBURY, G. REID; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. SCALABLE MULTIPLEXED MICROARRAY ASSAY FOR RECEP source ↗
- NIH award 1R43MH111295-01 FY2016: $213,765 awarded for that fiscal year; activity R43 (SBIR); PI ASBURY, G. REID; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. SCALABLE MULTIPLEXED MICROARRAY ASSAY FOR RECEP source ↗
- NIH award 5R44CA108390-03 FY2007: $581,738 awarded for that fiscal year; activity R44 (SBIR); PI SHI, CHAOFU; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. Analysis of Tumor RNA Variants using PMSG source ↗
- NIH award 2R44CA108390-02A1 FY2006: $646,382 awarded for that fiscal year; activity R44 (SBIR); PI TELMER, CHERYL A; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. Analysis of Tumor RNA Variants using PMSG source ↗
- NIH award 1R43CA110544-01 FY2004: $99,966 awarded for that fiscal year; activity R43 (SBIR); PI TELMER, CHERYL A; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. In Vitro Peptide Mass-Signature Genotyping of T source ↗
- NIH award 5R44GM060876-03 FY2004: $472,940 awarded for that fiscal year; activity R44 (SBIR); PI TELMER, CHERYL A; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. Cancer Genotyping by Peptide Mass Spectrometry source ↗
- NIH award 1R43CA108390-01 FY2004: $99,671 awarded for that fiscal year; activity R43 (SBIR); PI TELMER, CHERYL A; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. Detection of Tumor RNA Variants using PMSG source ↗
- NIH award 2R44GM060876-02 FY2003: $474,813 awarded for that fiscal year; activity R44 (SBIR); PI TELMER, CHERYL A; recipient as written: SPECTRAGENETICS, PITTSBURGH, PA. Cancer Genotyping by Peptide Mass Spectrometry source ↗